CompoAtlas

GARLIC OIL ORAL LIQUID

Natural health product licensed in Canada

Other names
ALLIIN ORAL LIQUID, COLOSSAL ALLIIN ORAL LIQUID, COLOSSAL GARLIC OIL ORAL LIQUID, COLOSSAL GARLIC ORAL LIQUID WITH ALLIIN, GARLIC ORAL LIQUID WITH ALLIIN
Licence holder
Canada Colossal Bio Group Co Ltd.
NPN or DIN-HM
80079010
Status
Active licence
Licence date
12 July 2017
Revision date
Not provided
Form
Liquide oral
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Allium sativum

Source : Bulbe

Potency : 6.3 milligramme Allicin

1.4 GrammesNot calculated
Allium sativum

Source : Bulbe

Potency : 14 milligramme Alliin

Not specifiedNot calculated
Allium sativum

Source : Bulbe

Not specifiedNot calculated

Non-medicinal ingredients

Vinaigre de cidre

PopulationAgeQuantity per servingFrequency
AdultesNot specified10 millilitre1 Tous les jours

Uses authorised in Canada

Traditionally used in Herbal Medicine to help relieve the symptoms associated with upper respiratory tract infections and catarrhal conditions. Used in Herbal Medicine to help reduce elevated blood lipid levels/ hyperlipidaemia in adults. Used in Herbal Medicine to help maintain cardiovascular health in adults.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80079010

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line